Acute and long-term cannabis use among stimulant users

Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial

Denise Vidot, Chad D. Rethorst, Tom J. Carmody, Mark Stoutenberg, Robrina Walker, Tracy L. Greer, Madhukar H. Trivedi

Research output: Contribution to journalArticle

Abstract

Aims: The aim of this study was to examine the impact of vigorous intensity, high dose exercise (DEI) on cannabis use among stimulant users compared to a health education intervention (HEI) using data from the Stimulant Reduction Intervention using Dosed Exercise, National Institute of Drug Abuse National Drug Treatment Clinical Trials Network Protocol Number 0037 (STRIDE). Methods: Adults (N = 302) enrolled in the STRIDE randomized clinical trial were randomized to either the DEI or the HEI. Interventions included supervised sessions three times a week during the Acute phase (12 weeks) and once a week during the Follow-up phase (6 months). Cannabis use was measured at each assessment via Timeline Follow Back and urine drug screens. Cannabis use was compared between the groups during the Acute and Follow-up phases using both the intent-to-treat sample and a complier average causal effects (CACE) analysis. Findings: Approximately 43% of the sample reported cannabis use at baseline. The difference in cannabis use between the DEI and HEI groups during the Acute phase was not significant. During the Follow-up phase, the days of cannabis use was significantly lower among those in the DEI group (1.20 days) compared to the HEI group (2.15 days; p = 0.04). Conclusions: For those who adhered to the exercise intervention, vigorous intensity, high dose exercise resulted in less cannabis use. Results suggest that there were no significant short-term differences in cannabis use between the groups. Further study on the long-term impact of exercise as a treatment to reduce cannabis use should be considered.

Original languageEnglish (US)
Pages (from-to)139-144
Number of pages6
JournalDrug and Alcohol Dependence
Volume200
DOIs
StatePublished - Jul 1 2019

Fingerprint

Cannabis
Health Education
Education
Health
Drug therapy
trans-crotonin
Clinical Protocols
Pharmaceutical Preparations
Substance-Related Disorders
Randomized Controlled Trials
Clinical Trials
Urine
Network protocols
Therapeutics

Keywords

  • Behavioral intervention
  • Cannabis
  • Exercise
  • Exercise intervention
  • Health behavior
  • Marijuana
  • Stimulants
  • STRIDE

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Acute and long-term cannabis use among stimulant users : Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial. / Vidot, Denise; Rethorst, Chad D.; Carmody, Tom J.; Stoutenberg, Mark; Walker, Robrina; Greer, Tracy L.; Trivedi, Madhukar H.

In: Drug and Alcohol Dependence, Vol. 200, 01.07.2019, p. 139-144.

Research output: Contribution to journalArticle

Vidot, Denise ; Rethorst, Chad D. ; Carmody, Tom J. ; Stoutenberg, Mark ; Walker, Robrina ; Greer, Tracy L. ; Trivedi, Madhukar H. / Acute and long-term cannabis use among stimulant users : Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial. In: Drug and Alcohol Dependence. 2019 ; Vol. 200. pp. 139-144.
@article{431d2bb1d5b34b5e8352e79a59675108,
title = "Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial",
abstract = "Aims: The aim of this study was to examine the impact of vigorous intensity, high dose exercise (DEI) on cannabis use among stimulant users compared to a health education intervention (HEI) using data from the Stimulant Reduction Intervention using Dosed Exercise, National Institute of Drug Abuse National Drug Treatment Clinical Trials Network Protocol Number 0037 (STRIDE). Methods: Adults (N = 302) enrolled in the STRIDE randomized clinical trial were randomized to either the DEI or the HEI. Interventions included supervised sessions three times a week during the Acute phase (12 weeks) and once a week during the Follow-up phase (6 months). Cannabis use was measured at each assessment via Timeline Follow Back and urine drug screens. Cannabis use was compared between the groups during the Acute and Follow-up phases using both the intent-to-treat sample and a complier average causal effects (CACE) analysis. Findings: Approximately 43{\%} of the sample reported cannabis use at baseline. The difference in cannabis use between the DEI and HEI groups during the Acute phase was not significant. During the Follow-up phase, the days of cannabis use was significantly lower among those in the DEI group (1.20 days) compared to the HEI group (2.15 days; p = 0.04). Conclusions: For those who adhered to the exercise intervention, vigorous intensity, high dose exercise resulted in less cannabis use. Results suggest that there were no significant short-term differences in cannabis use between the groups. Further study on the long-term impact of exercise as a treatment to reduce cannabis use should be considered.",
keywords = "Behavioral intervention, Cannabis, Exercise, Exercise intervention, Health behavior, Marijuana, Stimulants, STRIDE",
author = "Denise Vidot and Rethorst, {Chad D.} and Carmody, {Tom J.} and Mark Stoutenberg and Robrina Walker and Greer, {Tracy L.} and Trivedi, {Madhukar H.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1016/j.drugalcdep.2019.02.032",
language = "English (US)",
volume = "200",
pages = "139--144",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Acute and long-term cannabis use among stimulant users

T2 - Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial

AU - Vidot, Denise

AU - Rethorst, Chad D.

AU - Carmody, Tom J.

AU - Stoutenberg, Mark

AU - Walker, Robrina

AU - Greer, Tracy L.

AU - Trivedi, Madhukar H.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Aims: The aim of this study was to examine the impact of vigorous intensity, high dose exercise (DEI) on cannabis use among stimulant users compared to a health education intervention (HEI) using data from the Stimulant Reduction Intervention using Dosed Exercise, National Institute of Drug Abuse National Drug Treatment Clinical Trials Network Protocol Number 0037 (STRIDE). Methods: Adults (N = 302) enrolled in the STRIDE randomized clinical trial were randomized to either the DEI or the HEI. Interventions included supervised sessions three times a week during the Acute phase (12 weeks) and once a week during the Follow-up phase (6 months). Cannabis use was measured at each assessment via Timeline Follow Back and urine drug screens. Cannabis use was compared between the groups during the Acute and Follow-up phases using both the intent-to-treat sample and a complier average causal effects (CACE) analysis. Findings: Approximately 43% of the sample reported cannabis use at baseline. The difference in cannabis use between the DEI and HEI groups during the Acute phase was not significant. During the Follow-up phase, the days of cannabis use was significantly lower among those in the DEI group (1.20 days) compared to the HEI group (2.15 days; p = 0.04). Conclusions: For those who adhered to the exercise intervention, vigorous intensity, high dose exercise resulted in less cannabis use. Results suggest that there were no significant short-term differences in cannabis use between the groups. Further study on the long-term impact of exercise as a treatment to reduce cannabis use should be considered.

AB - Aims: The aim of this study was to examine the impact of vigorous intensity, high dose exercise (DEI) on cannabis use among stimulant users compared to a health education intervention (HEI) using data from the Stimulant Reduction Intervention using Dosed Exercise, National Institute of Drug Abuse National Drug Treatment Clinical Trials Network Protocol Number 0037 (STRIDE). Methods: Adults (N = 302) enrolled in the STRIDE randomized clinical trial were randomized to either the DEI or the HEI. Interventions included supervised sessions three times a week during the Acute phase (12 weeks) and once a week during the Follow-up phase (6 months). Cannabis use was measured at each assessment via Timeline Follow Back and urine drug screens. Cannabis use was compared between the groups during the Acute and Follow-up phases using both the intent-to-treat sample and a complier average causal effects (CACE) analysis. Findings: Approximately 43% of the sample reported cannabis use at baseline. The difference in cannabis use between the DEI and HEI groups during the Acute phase was not significant. During the Follow-up phase, the days of cannabis use was significantly lower among those in the DEI group (1.20 days) compared to the HEI group (2.15 days; p = 0.04). Conclusions: For those who adhered to the exercise intervention, vigorous intensity, high dose exercise resulted in less cannabis use. Results suggest that there were no significant short-term differences in cannabis use between the groups. Further study on the long-term impact of exercise as a treatment to reduce cannabis use should be considered.

KW - Behavioral intervention

KW - Cannabis

KW - Exercise

KW - Exercise intervention

KW - Health behavior

KW - Marijuana

KW - Stimulants

KW - STRIDE

UR - http://www.scopus.com/inward/record.url?scp=85065912413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065912413&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2019.02.032

DO - 10.1016/j.drugalcdep.2019.02.032

M3 - Article

VL - 200

SP - 139

EP - 144

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

ER -